INDUCTION AGENTS Dr. D.A.V. Sandeep kumar Consultant Dept. Anaesthesiology & Critical Care
Basic Principles of Anesthesia Anesthesia defined as the abolition of sensation Analgesia defined as the abolition of pain “ Triad of General Anesthesia” need for unconsciousness need for analgesia need for muscle relaxation
Inhalational Anesthetic Agents Inhalational anesthesia refers to the delivery of gases or vapors from the respiratory system to produce anesthesia Pharmacokinetics--uptake, distribution, and elimination from the body Pharmacodynamics -- MAC value
The main target of inhalation anesthetics is the brain.
Uptake and distribution of inhalational agents
MAC Minimum Alveolar Concentration = MAC. 1 MAC is the Minimum Alveolar Concentration at which 50 % of humans have no response (movement) to surgical stimulus (skin incision). MAC awake is the alveolar concentration when 50 % of persons will awake to vocal stimulus. Anesthetic potency is measured in MAC MAC is consistent within a species and between species. MAC is different for each inhaled agent.
AGENT MAC POTENCY Methoxy-flurane 0.16% Most potent Halothane 0.74% Isoflurane 1.17% Enflurane 1.7% sevoflurane 2.05% desflurane 6.0% Nitrous oxide 104% Least potent
Amber colored bottled – red colour coding Thymol preservative. Pleasant smell , non-irritant, bronco-dilatation, potent to induce in single puff make it best for paediatric induction . Agent of choice for asthmatics . Not a good analgesic
Most potent inhalational anesthetic MAC of 0.75% Efficacious in depressing consciousness Very soluble in blood and adipose B:G p co- ef .- 2.4 Prolonged emergence Halothane
Inhibits sympathetic response to painful stimuli Inhibits sympathetic driven baroreflex response ( hypovolemia ) Depresses myocardium-- lowers BP and slows conduction Sensitizes myocardium to effects of exogenous catecholamines -- ventricular arrhythmias Halothane Systemic Effects
Halothane Systemic Effects Decreases respiratory drive-- central response to CO 2 and peripheral to O 2 Respirations shallow-- atelectasis Depresses protective airway reflexes Potent Bronchodilator Marked increase in ICT
Normal liver Halothane hepatitis Avoid halothane repeat exposure with in 3 months. Halothane Side Effects “Halothane Hepatitis” Pathological lesion is Centrilobar necrosis
Halothane Side Effects Malignant Hyperthermia- Classic-- rapid rise in body temperature, muscle rigidity, tachycardia, rhabdomyolysis , acidosis, hyperkalemia , DIC most common masseter rigidity Treatment - IV dantrolene
Contraindications/Precautions Malignant hyperthermia. susceptibility unexplained liver dysfunction after previous halothane exposure intracranial mass lesion aortic stenosis pheochromocytoma with aminophylline has been associated with severe ventricular dysrhythmias
Enflurane First to Isoflurane Stable, nonflammable liquid Pungent odor MAC 1.68%
Enflurane Systemic Effects Potent inotropic and chronotropic depressant and decreases systemic vascular resistance-- lowers blood pressure and conduction dramatically Inhibits sympathetic baroreflex response Sensitizes myocardium to effects of exogenous catecholamines -- arrhythmias
Enflurane Systemic Effects Respiratory drive is greatly depressed-- central and peripheral responses Increases ICT
Isoflurane Isomer of Enflurane Not carcinogenic Nonflammable Pungent MAC of 1.30 % B:G p co- ef is 1.17
Only agent that preserves baroreceptor reflex – isof . So that reflex tachycardia occurs in response to decrease B.P mantaining cardiac output. Agent of choice for controlled hypotension is isof . Excellent muscle relaxant-- potentiates effects of neuromuscular blockers Isoflurane Systemic Effects
Agent that cause coronary steal – isof . Agent of choice for cardiac anaesthesia as it doesn’t sensitize myocardium to adrenaline except MI Agent that causes minimal increase in intracranial tension & decreases Brain’s oxygenation demand is isof . Agent of choice for neuroanaesthesia . Isoflurane Systemic Effects
Isoflurane Side Effects Little metabolism (0.2%) -- low potential of organotoxic metabolites No EEG activity like enflurane Bronchoirritating , laryngospasm
Sevoflurane
Low solubility in blood-- produces rapid induction and emergence Pleasant smell , non irritant and bronchodilatation makes it agent of choice for Paediatric anaesthesia . 2 nd agent of choice for Neuro anaesthesia . Cardiac anaesthesia . asthmatics
Sevoflurane Minimal systemic effects-- mild respiratory and cardiac suppression Decreases portal blood flow but increases hepatic artery blood flow, so Hepatic blood flow is maintained Expensive
Sevoflurane and Compound A Sevoflurane reacts with soda lime used in anesthetic circuit to form “compound A” Mostly with Barylime compound A is renal toxin. Agents that should not be given with sodalime . 1) trielene .( trichlor ethylene) 2) sevoflurane . 3) desflurane
Desflurane
Pungent odour Agent that boils at room temperature(22.8*c)-DF. Agent of choice for day care (fastest induction )- DF. Does not cause coronary steal Stimulates Sympathetic system, so can be given to pt’s in SHOCK Agent of choice for geriatric (old) patients – DF. Agent of choice for hepatic failure Agent of choice for renal failure
Anesthetic B:G PC MAC Features Notes Halothane 2.3 0.74% PLEASANT Arrhythmia Hepatitis Hyperthermia Enflurane 1.9 1.69% PUNGENT Seizures Hyperthermia Isoflurane 1.4 1.17% PUNGENT Widely used Sevoflurane 0.62 1.92% PLEASANT Ideal Desflurane 0.42 6.1% IRRITANT Cough Nitrous 0.47 104% PLEASANT Anemia Review
Thiopentone Barbiturate Water soluble Alkaline Dose-dependent suppression of CNS activity--decreased cerebral metabolic rate (EEG flat)
Yellow Amorphous powder On dilution as 2.5 % , pH is 10.8 Should not be diluted with RL Sulphur makes it Lipid soluble Sodium salt makes Water soluble Ultra short duration due to Methyl group Prepared in atmosphere of Nitrogen
Unconsciousness in one arm brain circulation time (15 s) Regains consciousness due to Redistribution Metabolised in Liver , excreted in Kidney MOA – inhibitory neurotransmitters like GABA is enhanced , GABA mimetic action
Thiopental Systemic Effects Varied effects on cardiovascular system in people-- mild direct cardiac depression-- lowers blood pressure-- compensatory tachycardia ( baroreflex ) Dose-dependent depression of respiration, depth affected more than rate
Cerebral oxygen consumption, cerebral metabolic rate & ICT are decreased, so agent of choice for Cerebral protection Anticonvulsant action due to phenyl group, controls convulsions resistant to other anticonvulsants Anti - analgesic action Decreases IOP Has Anti-thyroid activity
Dose – 4-6 mg/kg b.w Due to redistribution, drug is eliminated after 10-12 hrs, so should be under observation for 24 hrs
Thiopental Side Effects High Alkalinity causes Tissue necrosis—gangrene due to perivenous or intramuscular inj. Rx – 10 ml 1% lignocaine , 100 u hyaluronidase locally
Intra arterial inj is dreadful complication - Precipitation & crystallization due to acidic pH of blood -Thrombus – blocked microcirculation,vasospasm – ischemia & Gangrene - Rx – leave needle at site - inj. Heparin 500 u, - inj. papaverine 40mg - inj. Xylocaine 1% 10ml - brachial plexus or stellate ganglion block
Contra Indications Porphyrias – mostly in Acute Intermittent Porphyria and Variegate Porphyria Shock and Hypotension Asthmatics
Methohexitone More potent than Thiopentone Used as1% solution with pH - 11.1 Dose – 1.5 mg/kg Given IM or perrectal in children Induces Seizures, so agent of choice for ECT.
Consists of phenol ring with isopropyl group Oil based preparation consisting soyabean oil, egg lecithin and glycerol. Hence milky white in colour Painful injection, preceded by Lignocaine Rapid onset and short duration of action Propofol
Induced in one arm brain circulation time Duration of action 5 – 10 min’s Dose 2 mg/kg b.w Metabolised by liver and excreted by kidney
Propofol Hypotension produced is significant Respiratory depression is more severe Produces muscle twitchings & myoclonic activity Antiemetic Antipruritic Reduces IOP
Uses Agent of choice for Day care surgery Agent of choice for Total Intravenous anaesthesia (TIVA) Infusion used for ICU sedation Agent of choice in susceptible pt’s of Malignant Hyperthermia
Disadvantages Apnea is more profound Hypotension is more severe Injection is painful Myoclonic activity Allergic reactions due to egg lecithin
Ketamine Phencyclidine derivative with Imidazole ring Contains Benzethonium chloride as preservative Acidic in nature – pH 3.5 Highly lipid soluble Dose – 2 mg/kg bw IV, 5 mg/kg bw IM
Onset of action 30 – 60 s Duration of action 15 to 20 min’s , because of redistribution Strong Analgesic Metabolised by liver, eliminated by kidney
Primary site of action – thalamo -neocortical projection It inhibits Cortex (unconscious) , thalamus (analgesia) and stimulates limbic system (emergence reaction and hallucinations) Hence called as Dissociative anaesthesia Action on NMDA receptors
Ketamine Systemic and Side Effects ICT is raised Hallucinations most common , minimised by Midazolam Characteristic of sympathetic nervous system stimulation-- increase HR, BP, CO , so IV agent of choice in Shock
Maintains laryngeal reflexes and skeletal muscle tone Potent Bronchodilator , so IV agent of choice in Asthmatics Tracheobronchial and salivary secretions are increased Increases Intraocular tension Increases Intragastric tension
USES Induction agent of choice in asthmatics, shock and children Sole agent in minor procedures Used in remote places Preferred in full stomach as reflexes are preserved
Contra Indications Head injury Eye injury Ischemic heart disease Hypertensives Psychiatric pts
Etomidate Structure similar to ketoconozole Cardiovascular stable agent , so Anaesthetic of choice for Aneurysm surgery Dose 0.3 mg/kg b.w
Etomidate Systemic Effects Little change in cardiac function in healthy and cardiac patients Mild dose-related respiratory depression Decreased cerebral metabolism
Etomidate Side Effects Pain on injection (propylene glycol) Myoclonic activity Nausea and vomiting (50%) Adreno Cortical suppression Vitamin C deficiency